Specify a stock or a cryptocurrency in the search bar to get a summary
Memphasys Ltd
MEMMemphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix, a device separates sperm from raw semen by electrophoresis process for use in human IVF procedures. In addition, the company's product pipeline include ROSA, a rapid oxidative stress assay; Samson Device, rapid equine pregnancy prediction assay; SemPort, a system that allows transport of semen; and AI-Port. Further, it provides ambient temperature storage product for human sperm. Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia. Address: 30 Richmond Road, Homebush, NSW, Australia, 2140
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures MEM
Dividend Analytics MEM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MEM
Stock Valuation MEM
Financials MEM
Results | 2019 | Dynamics |